These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 36843759

  • 1. Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy.
    Ghazal F, Zur M, Silver A.
    Cureus; 2023 Jan; 15(1):e34121. PubMed ID: 36843759
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report.
    Lim D, Landon-Cardinal O, Ellezam B, Belisle A, Genois A, Sirois J, Bourré-Tessier J.
    SAGE Open Med Case Rep; 2020 Jan; 8():2050313X20984120. PubMed ID: 33447390
    [Abstract] [Full Text] [Related]

  • 6. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
    Williams B, Horn MP, Banz Y, Feldmeyer L, Villiger PM.
    J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
    [Abstract] [Full Text] [Related]

  • 9. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL.
    Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
    Klein M, Mann H, Pleštilová L, Zámečník J, Betteridge Z, McHugh N, Vencovský J.
    Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I, Casal-Dominguez M, Mammen AL.
    Curr Rheumatol Rep; 2018 Mar 26; 20(4):21. PubMed ID: 29582188
    [Abstract] [Full Text] [Related]

  • 15. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I.
    Medicine (Baltimore); 2015 Jan 26; 94(4):e416. PubMed ID: 25634171
    [Abstract] [Full Text] [Related]

  • 16. Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report.
    Thomas R, Yeoh SA, Berkeley R, Woods A, Stevens M, Marino S, Radunovic A.
    BMC Rheumatol; 2020 Jan 26; 4():29. PubMed ID: 32613157
    [Abstract] [Full Text] [Related]

  • 17. Immune mediated necrotizing myopathy: A rare complication of statin therapy.
    Abusharar SP, Moku P, Banks S, Khalid FM, Specht CS, Polimera HV.
    Clin Pract; 2020 May 19; 10(2):1248. PubMed ID: 32670535
    [Abstract] [Full Text] [Related]

  • 18. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M, Fite C, Kottler D, Maisonobe L, Dossier A, Deschamps L, Descamps V.
    Ann Dermatol Venereol; 2019 Sep 19; 146(8-9):550-556. PubMed ID: 30929872
    [Abstract] [Full Text] [Related]

  • 19. Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report.
    Upreti S, Fayyaz B, Bongu RP.
    J Community Hosp Intern Med Perspect; 2019 Sep 19; 9(1):33-35. PubMed ID: 30788073
    [Abstract] [Full Text] [Related]

  • 20. Statin-Associated Autoimmune Myopathy: Current Perspectives.
    Tiniakou E.
    Ther Clin Risk Manag; 2020 Sep 19; 16():483-492. PubMed ID: 32581543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.